Article information
Full text is only aviable in PDF
Bibliografía
[1.]
Ministerio de Sanidad y Consumo.
Simposio Nacional del Síndrome Tóxico.
Ministerio de Sanidad y Consumo. Madrid, (1982),
[2.]
A. Rodríguez Noriega, J.J. Gómez Reino, A. López Encuentra, P. Martín Escribano, J.A. Solís Herruzo.
Valle Jiménez. Toxic epidemic syndrome. Spain 1981.
Lancet, ii (1982), pp. 697-702
[3.]
F.J. Martínez Tello, J.J. Navas Palacios, J.R. Ricoy, R. Gil Martín, J.M. Conde Zurita, F. Colina Ruiz Delgado, I. Téllez, A. Cabello, S. Madero García.
Pathology of a new toxic syndrome caused by ingestión of adulterated oil in Spain.
Virchows Arch (Pathol Anat), 397 (1982), pp. 261-285
[4.]
Instituto Nacional de la Salud. Programa de salud para el Síndrome tóxico en Atención primaria.
Ministerio de Sanidad y Consumo. Julio, (1986),
[5.]
J.M. Tabuenca.
Toxic-allergic syndrome caused by ingestion of rapeseed oil denaturated with aniline.
Lancet, (1981), pp. 567-568
[6.]
J.G. Rigau Pérez, L. Pérez Alvarez, S. Dueñas Castro.
Epidemiologic investigation of an oil associated pneumonia paralytic eosinophilic syndrome in Spain.
Am J Epidemiol, 119 (1984), pp. 250-260
[7.]
R. Cañas, E.M. Kilbourne.
Oil ingestion and the toxic oil syndrome: results of a survey of residents of the Orcasur neighbourhood in Madrid.
Spain. Inter J Epidemiol, 16 (1987), pp. 3-6
[8.]
E.M. Kilbourne, J.T. Bernert, M. Posada de la Paz, R.H. Hill, I. Abaitua Borda, B.W. Kilbourne, M.M. Zack.
Toxic-Epidemiologic Study Group Chemical correlatos of pathogenicity of oils related to the toxic oil syndrome epidemic in Spain.
Am J Epidemiol, 127 (1988), pp. 1210-1227
[9.]
R.D. Kimbrough.
Animal studies with spanish cooking oil and fatty acid anilides at the Center for Disease Control.
Who. Toxic rapeseed oil, 54 (1983),
[10.]
A. Kupfer, R. Preisig.
Inherited defects of hepatic drug metabolism.
Semin Liver Dis, 3 (1983), pp. 341-354
[11.]
S. Chaplin.
Genetically determined differences in susceptibility to adverse drug reactions.
Adv Drug Reac Ac Pois Rev, 4 (1984), pp. 211-236
[12.]
R.F. Del Maestro.
An approach to free radicals in medicine and biology.
Acta Physiol Scand, 492 (1980), pp. 153-168
[13.]
F.J. Valle Gutiérrez, A. Rodríguez Noriega, A. López Encuentra, J. Gómez Reino, P. Martín Escribano, J.A. Solís Herruzo.
Radicales libres (RL); Hipótesis patogénica explicatoria del síndrome tóxico. Simposio Nacional Síndrome Tóxico.
Ministerio de Sanidad y Consumo, (1982),
[14.]
U.S. Ryan, J.W. Ryan.
Cell biology of pulmonary endothelium.
Circulation, 70 (1984), pp. 77-82
[15.]
F. Díaz de Rojas, M. Castro García, I. Abaitua Borda, M. Posada de la Paz, J.M. Tabuenca Oliver.
Hepatic injury in the toxic oil syndrome.
Hepatology, 5 (1985), pp. 166-169
[16.]
J.R. Ricoy, A. Cabello, J. Rodríguez, I. Téllez.
Neuropathological studies in the toxic oil syndrome related to adulterated oil in Spain.
Brain, 106 (1983), pp. 817-835
[17.]
V. Vidal Ruiz, M. Ramis Pedromingo, M.J. Díaz de Atauri.
Prevalencia de clínica digestiva en las fases crónica del síndrome del aceite tóxico.
Gastroenterol y Hepatol, 10 (1987), pp. 11-15
[18.]
I.M. Mateo, M. Izquierdo, M.P. Fernández Dopico, J. Navas, A. Cabello, J.J. Gómez Reino.
Toxic epidemic syndrome: Musculoskeletal manifestations.
J Rheumatol, 11 (1984), pp. 333-338
[19.]
C. Casáis, P. García Barreno, A.M. Municio.
Lipogenesis in liver, lung and adipose tissue of rats fed with oleoanilides.
Biochem J, 212 (1983), pp. 339-344
[20.]
E.K. Weir, R.F. Grover.
The role of endogeneous prostaglandins in the pulmonary circulation.
Anesthesiology, 48 (1978), pp. 201-212
[21.]
P.H. Levile, D.G. Sladdin, N.I. Kinsky.
Superoxide, xantine oxidase and platelets.
Throm Heamost, 45 (1981), pp. 290-293
[22.]
H.B. Demopoulos, E.S. Flamm, D.D. Pietronigro, H.L. Seligman.
The free radical pathology and the microcirculation in the major central system disorders.
Acta Physiol Scand, 492 (1980), pp. 91-119
[23.]
C. Lahoz, L. Tricas, C. Vela, P. Lauzurica, C. Gurbindo, R. García, IgE. Hyper.
eosinophilia and immunological hyperreactivity due to ingestión of adulterated rapeseed oil (toxic oil syndrome).
Eur J Respir Dis, 64 (1983), pp. 415-418
[24.]
G. Gutiérrez, L. Gaspar, R. Muro, M. Kreisler, P. Ferriz.
Autoimmunity in patients with spanish toxic oil syndrome.
Lancet, i (1983), pp. 644
[25.]
R.S. Pereira, C.M. Black, A. Arnaiz Villena, J.L. Vicario, J.J. Gómez Reino.
Collagen antibodies in toxic oil syndrome.
Lancet, i (1985), pp. 273
[26.]
A.P. Fischman.
Plexiform lessions.
Pathol Microbiol (Basel), 43 (1975), pp. 242
[27.]
Gómez Sánchez MA, Mestre de Juan MJ, Gómez Pajuelo C, López JI, Díaz de Atauri MJ, Martínez Tello FJ. Pulmonary hypertension due to toxic oil syndrome: a clinicopathological study. Chest.(en prensa).
[28.]
J.L. Vicario, M. Serrano Ríos, F. San Andrés, A. Arnaiz Villena.
HLA DR3/DR4 increase in chronic stage of spanish oil disease.
Lancet, i (1982), pp. 276
[29.]
C.W. Castor, J.C. Ritchie, C.H. Williams Jr., M.E. Scot, S.L. Whitney, S.L. Myers, T.B. Sloan, B.E. Anderson.
Connective tissue activation.
XIV Composition and actions of a human platelet autacoid mediator. Arthrit and Rheum, 22 (1979), pp. 260-272
[30.]
P.M. Campbell, E.C. LeRoy.
Pathogenesis of systemic sclerosis: a vascular hypothesis.
Semin in Arthrit and Rheum, 4 (1975), pp. 351-368
[31.]
N. Voelkel, J.T. Reeves.
Primary pulmonary hypertension.
Pulmonary vascular ed, pp. 573-628
[32.]
A.E. Postlethwaite, L.B. Lachman, A.H. Kang.
Induction of fibroblast proliferation by interleukin I derived from human monocytic leukemia cells.
Arthritis and Rheum, 27 (1984), pp. 995-1001
[33.]
D.J. Wyler.
Eosinophils contain fibroblast stimulating factor.
Clinical Research, 29 (1981), pp. 379A
[34.]
Harley JB. Clinical manifestations of patients with hypereosinophilic syndrome. En: Fauci AS, Moderator: Clinical, Pathophysiologic and therapeutic considerations. Ann Intern Med 1982; 97:78-92.
[35.]
M. Posada, J.M. Alonso, M. Castro, F. Díaz de Rojas, I. Abaitua, J.M. Tabuenca.
Toxic oil syndrome, scleroderma and eosinophilic fascitis.
Arthrit and Rheum, 27 (1984), pp. 1200
[36.]
A. López Encuentra, M.J. Díaz Atauri, M.J. Domínguez Lozano, P. Martín Escribano.
Patología pulmonar. Simposio Nacional Síndrome Tóxico.
Ministerio de Sanidad y Consumo, (1982),
[37.]
P. Martín Escribano, J.M. Fernández Sánchez-Alarcos, M.J. Domínguez Lozano, M.J. Díaz de Atauri, C. Barbosa Ayúcar, A. Cantalapiedra, A. López Encuentra.
Exploration fonctionelle pulmonaire aux differentes stades du syndrome du a 1’huile toxique.
Bull Europ Physiopathol Respir, 20 (1984), pp. 307-312
[38.]
M.J. Díaz de Atauri, P. Martín Escribano, M.A. Gómez Sánchez.
Persistencia de alteraciones funcionales respiratorias en pacientes con síndrome del aceite tóxico.
Arch Bronconeumol, 23 (1987), pp. 61
[39.]
L.A. Oteo, J.L. de la Cruz, J. Picher, L.M. Martín, A. Sueiro.
Aspectos morfológicos del síndrome tóxico español.
Med Clin (Barcelona), 79 (1982), pp. 1-8
[40.]
T. Del Ser Quijano, A. Esteban García, P. Martínez Martín, M.A. Morales Otal, M. Pondal Sordo, P. Pérez Vergara, A. Portera Sánchez.
Evolución de la afectación neuromuscular en el síndrome del aceite tóxico.
Med Clin (Barc), 87 (1986), pp. 231-236
[41.]
M.A. Gómez Sánchez.
Estudio clínico, hemodinámico y anatomopatológico de la hipertensión arterial pulmonar severa por síndrome del aceite tóxico.
Tesis Doctoral. Universidad Complutense, Madrid, (1988),
[42.]
E. Fonseca Capdevila, J. Soto Melo, F. Contreras Rubio, P. Maza León, M. Miranda Fontés.
Manifestaciones cutáneas del síndrome tóxico por aceite adulterado. Simposio Nacional Síndrome Tóxico.
Ministerio de Sanidad y Consumo, (1982),
Copyright © 1989. Sociedad Española de Neumología y Cirugía Torácica
